BMO Keeps ISIS Pharma (ISIS) at 'Outperform' Following ISIS-BIIB4Rx Milestone
Tweet Send to a Friend
BMO Capital affirms Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) at Outperform with a price target of $75 after the company announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
